This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alvar, J.
Right arrow Articles by Moreno, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alvar, J.
Right arrow Articles by Moreno, J.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, 04 1997, 298-319, Vol 10, No. 2
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Leishmania and human immunodeficiency virus coinfection: the first 10 years

J Alvar, C Canavate, B Gutierrez-Solar, M Jimenez, F Laguna, R Lopez-Velez, R Molina and J Moreno
Laboratorio de Referencia de Leishmaniasis, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.

Over 850 Leishmania-human immunodeficiency virus (HIV) coinfection cases have been recorded, the majority in Europe, where 7 to 17% of HIV- positive individuals with fever have amastigotes, suggesting that Leishmania-infected individuals without symptoms will express symptoms of leishmaniasis if they become immunosuppressed. However, there are indirect reasons and statistical data demonstrating that intravenous drug addiction plays a specific role in Leishmania infantum transmission: an anthroponotic cycle complementary to the zoonotic one has been suggested. Due to anergy in patients with coinfection, L. infantum dermotropic zymodemes are isolated from patient viscera and a higher L. infantum phenotypic variability is seen. Moreover, insect trypanosomatids that are currently considered nonpathogenic have been isolated from coinfected patients. HIV infection and Leishmania infection each induce important analogous immunological changes whose effects are multiplied if they occur concomitantly, such as a Th1-to- Th2 response switch; however, the consequences of the viral infection predominate. In fact, a large proportion of coinfected patients have no detectable anti-Leishmania antibodies. The microorganisms share target cells, and it has been demonstrated in vitro how L. infantum induces the expression of latent HIV-1. Bone marrow culture is the most useful diagnostic technique, but it is invasive. Blood smears and culture are good alternatives. PCR, xenodiagnosis, and circulating-antigen detection are available only in specialized laboratories. The relationship with low levels of CD4+ cells conditions the clinical presentation and evolution of disease. Most patients have visceral leishmaniasis, but asymptomatic, cutaneous, mucocutaneous, diffuse cutaneous, and post-kala-azar dermal leishmaniasis can be produced by L. infantum. The digestive and respiratory tracts are frequently parasitized. The course of coinfection is marked by a high relapse rate. There is a lack of randomized prospective treatment trials; therefore, coinfected patients are treated by conventional regimens. Prophylactic therapy is suggested to be helpful in preventing relapses.


This article has been cited by other articles:

  • Romero, H. D., de Almeida Silva, L., Silva-Vergara, M. L., Rodrigues, V., Costa, R. T., Guimaraes, S. F., Alecrim, W., Moraes-Souza, H., Prata, A. (2009). Comparative Study of Serologic Tests for the Diagnosis of Asymptomatic Visceral Leishmaniasis in an Endemic Area. Am J Trop Med Hyg 81: 27-33 [Abstract] [Full Text]  
  • Patel, K. K., Patel, A. K., Sarda, P., Shah, B. A., Ranjan, R. (2009). Immune Reconstitution Visceral Leishmaniasis Presented as Hemophagocytic Syndrome in a Patient With AIDS From a Nonendemic Area: A Case Report. J Int Assoc Physicians AIDS Care (Chic Ill) 8: 217-220 [Abstract]  
  • Wadhone, P., Maiti, M., Agarwal, R., Kamat, V., Martin, S., Saha, B. (2009). Miltefosine Promotes IFN-{gamma}-Dominated Anti-Leishmanial Immune Response. J. Immunol. 182: 7146-7154 [Abstract] [Full Text]  
  • Serrano-Martin, X., Garcia-Marchan, Y., Fernandez, A., Rodriguez, N., Rojas, H., Visbal, G., Benaim, G. (2009). Amiodarone Destabilizes Intracellular Ca2+ Homeostasis and Biosynthesis of Sterols in Leishmania mexicana. Antimicrob. Agents Chemother. 53: 1403-1410 [Abstract] [Full Text]  
  • Alborzi, A., Pourabbas, B., Shahian, F., Mardaneh, J., Pouladfar, G. R., Ziyaeyan, M. (2008). Detection of Leishmania infantum Kinetoplast DNA in the Whole Blood of Asymptomatic Individuals by PCR-ELISA and Comparison with Other Infection Markers in Endemic Areas, Southern Iran. Am J Trop Med Hyg 79: 839-842 [Abstract] [Full Text]  
  • Martinez-Giron, R., Esteban, J. G., Ribas, A., Doganci, L. (2008). Protozoa in respiratory pathology: a review. Eur Respir J 32: 1354-1370 [Abstract] [Full Text]  
  • Morio, F., Reynes, J., Dollet, M., Pratlong, F., Dedet, J.-P., Ravel, C. (2008). Isolation of a Protozoan Parasite Genetically Related to the Insect Trypanosomatid Herpetomonas samuelpessoai from a Human Immunodeficiency Virus-Positive Patient. J. Clin. Microbiol. 46: 3845-3847 [Abstract] [Full Text]  
  • Fisa, R., Riera, C., Lopez-Chejade, P., Molina, I., Gallego, M., Falco, V., Ribera, E., Portus, M. (2008). Leishmania infantum DNA Detection in Urine from Patients with Visceral Leishmaniasis and after Treatment Control. Am J Trop Med Hyg 78: 741-744 [Abstract] [Full Text]  
  • Alvar, J., Aparicio, P., Aseffa, A., Den Boer, M., Canavate, C., Dedet, J.-P., Gradoni, L., Ter Horst, R., Lopez-Velez, R., Moreno, J. (2008). The Relationship between Leishmaniasis and AIDS: the Second 10 Years. Clin. Microbiol. Rev. 21: 334-359 [Abstract] [Full Text]  
  • Tuon, F. F., Amato, V. S., Bacha, H. A., AlMusawi, T., Duarte, M. I., Amato Neto, V. (2008). Toll-Like Receptors and Leishmaniasis. Infect. Immun. 76: 866-872 [Full Text]  
  • Molina, I., Falco, V., Crespo, M., Riera, C., Ribera, E., Curran, A., Carrio, J., Diaz, M., Villar del Saz, S., Fisa, R., Lopez-Chejade, P., Ocana, I., Pahissa, A. (2007). Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients. J Antimicrob Chemother 60: 837-842 [Abstract] [Full Text]  
  • SOLANO-GALLEGO, L., RODRIGUEZ-CORTES, A., INIESTA, L., QUINTANA, J., PASTOR, J., ESPADA, Y., PORTUS, M., ALBEROLA, J. (2007). CROSS-SECTIONAL SEROSURVEY OF FELINE LEISHMANIASIS IN ECOREGIONS AROUND THE NORTHWESTERN MEDITERRANEAN. Am J Trop Med Hyg 76: 676-680 [Abstract] [Full Text]  
  • Piscopo, T. V, Mallia Azzopardi, C. (2007). Leishmaniasis.. Postgrad. Med. J. 83: 649-657 [Abstract] [Full Text]  
  • Garcia-Garcia, J. A., Martin-Sanchez, J., Gallego, M., Rivero-Roman, A., Camacho, A., Riera, C., Morillas-Marquez, F., Vergara, S., Macias, J., Pineda, J. A. (2006). Use of Noninvasive Markers To Detect Leishmania Infection in Asymptomatic Human Immunodeficiency Virus-Infected Patients. J. Clin. Microbiol. 44: 4455-4458 [Abstract] [Full Text]  
  • DE ALMEIDA SILVA, L., ROMERO, H. D., PRATA, A., COSTA, R. T., NASCIMENTO, E., CARVALHO, S. F. G., RODRIGUES, V. (2006). IMMUNOLOGIC TESTS IN PATIENTS AFTER CLINICAL CURE OF VISCERAL LEISHMANIASIS.. Am J Trop Med Hyg 75: 739-743 [Abstract] [Full Text]  
  • Piscopo, T V, Mallia, A C (2006). Leishmaniasis.. Postgrad. Med. J. 82: 649-657 [Abstract] [Full Text]  
  • Hassan, M. F., Zhang, Y., Engwerda, C. R., Kaye, P. M., Sharp, H., Bickle, Q. D. (2006). The Schistosoma mansoni Hepatic Egg Granuloma Provides a Favorable Microenvironment for Sustained Growth of Leishmania donovani. Am. J. Pathol. 169: 943-953 [Abstract] [Full Text]  
  • Cruz, I., Chicharro, C., Nieto, J., Bailo, B., Canavate, C., Figueras, M.-C., Alvar, J. (2006). Comparison of new diagnostic tools for management of pediatric mediterranean visceral leishmaniasis.. J. Clin. Microbiol. 44: 2343-2347 [Abstract] [Full Text]  
  • Mathur, P., Samantaray, J. C., Vajpayee, M., Samanta, P. (2006). Visceral leishmaniasis/human immunodeficiency virus co-infection in India: the focus of two epidemics.. J Med Microbiol 55: 919-922 [Abstract] [Full Text]  
  • Zhao, C., Thibault, S., Messier, N., Ouellette, M., Papadopoulou, B., Tremblay, M. J. (2006). In primary human monocyte-derived macrophages exposed to Human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake?. J. Gen. Virol. 87: 1295-1302 [Abstract] [Full Text]  
  • DA SILVA MENDES, W., BRANCO, M. D. R. F. C., MEDEIROS, M. N. L. (2006). Clinical case report: dengue hemorrhagic Fever in a patient with acquired immunodeficiency syndrome.. Am J Trop Med Hyg 74: 905-907 [Abstract] [Full Text]  
  • Stark, D., Pett, S., Marriott, D., Harkness, J. (2006). Post-Kala-Azar Dermal Leishmaniasis Due to Leishmania infantum in a Human Immunodeficiency Virus Type 1-Infected Patient.. J. Clin. Microbiol. 44: 1178-1180 [Abstract] [Full Text]  
  • St. George, S., Bishop, J. V., Titus, R. G., Selitrennikoff, C. P. (2006). Novel Compounds Active against Leishmania major. Antimicrob. Agents Chemother. 50: 474-479 [Abstract] [Full Text]  
  • Seifert, K., Croft, S. L. (2006). In Vitro and In Vivo Interactions between Miltefosine and Other Antileishmanial Drugs. Antimicrob. Agents Chemother. 50: 73-79 [Abstract] [Full Text]  
  • RIERA, C., FISA, R., RIBERA, E., CARRIO, J., FALCO, V., GALLEGO, M., MONER, L., MOLINA, I., PORTUS, M. (2005). VALUE OF CULTURE AND NESTED POLYMERASE CHAIN REACTION OF BLOOD IN THE PREDICTION OF RELAPSES IN PATIENTS CO-INFECTED WITH LEISHMANIA AND HUMAN IMMUNODEFICIENCY VIRUS. Am J Trop Med Hyg 73: 1012-1015 [Abstract] [Full Text]  
  • van der Meide, W. F., Schoone, G. J., Faber, W. R., Zeegelaar, J. E., de Vries, H. J. C., Ozbel, Y., Lai A Fat, R. F. M., Coelho, L. I. A. R. C., Kassi, M., Schallig, H. D. F. H. (2005). Quantitative Nucleic Acid Sequence-Based Assay as a New Molecular Tool for Detection and Quantification of Leishmania Parasites in Skin Biopsy Samples. J. Clin. Microbiol. 43: 5560-5566 [Abstract] [Full Text]  
  • Sanchez-Robert, E., Altet, L., Sanchez, A., Francino, O. (2005). Polymorphism of Slc11a1 (Nramp1) Gene and Canine Leishmaniasis in a Case-Control Study. J Hered 96: 755-758 [Abstract] [Full Text]  
  • SUNDAR, S., AGRAWAL, S., PAI, K., CHANCE, M., HOMMEL, M. (2005). DETECTION OF LEISHMANIAL ANTIGEN IN THE URINE OF PATIENTS WITH VISCERAL LEISHMANIASIS BY A LATEX AGGLUTINATION TEST. Am J Trop Med Hyg 73: 269-271 [Abstract] [Full Text]  
  • SARIDOMICHELAKIS, M. N., MYLONAKIS, M. E., LEONTIDES, L. S., KOUTINAS, A. F., BILLINIS, C., KONTOS, V. I. (2005). EVALUATION OF LYMPH NODE AND BONE MARROW CYTOLOGY IN THE DIAGNOSIS OF CANINE LEISHMANIASIS (LEISHMANIA INFANTUM) IN SYMPTOMATIC AND ASYMPTOMATIC DOGS. Am J Trop Med Hyg 73: 82-86 [Abstract] [Full Text]  
  • Murray, H. W. (2005). Prevention of Relapse after Chemotherapy in a Chronic Intracellular Infection: Mechanisms in Experimental Visceral Leishmaniasis. J. Immunol. 174: 4916-4923 [Abstract] [Full Text]  
  • DE SOUZA DIAS, S., DA COSTA PINHEIRO, P. H., KATZ, S., SANTOS, M. R. M. D., BARBIERI, C. L. (2005). A RECOMBINANT CYSTEINE PROTEINASE FROM LEISHMANIA (LEISHMANIA) CHAGASI SUITABLE FOR SERODIAGNOSIS OF AMERICAN VISCERAL LEISHMANIASIS. Am J Trop Med Hyg 72: 126-132 [Abstract] [Full Text]  
  • Anton, E., Lopez, A., Marti, J. (2005). An Unusual Presentation of Cutaneous Leishmaniasis. Arch Dermatol 141: 109-110 [Full Text]  
  • GARROTE, J. I., GUTIERREZ, M. P., IZQUIERDO, R. L., DUENAS, M. A. I., ZARZOSA, P., CANAVATE, C., BALI, M. E., ALMARAZ, A., BRATOS, M. A., BERBEL, C., RODRIGUEZ-TORRES, A., DOMINGO, A. O. (2004). SEROEPIDEMIOLOGIC STUDY OF LEISHMANIA INFANTUM INFECTION IN CASTILLA-LEON, SPAIN. Am J Trop Med Hyg 71: 403-406 [Abstract] [Full Text]  
  • Sanchez-Brunete, J. A., Dea, M. A., Rama, S., Bolas, F., Alunda, J. M., Raposo, R., Mendez, M. T., Torrado-Santiago, S., Torrado, J. J. (2004). Treatment of Experimental Visceral Leishmaniasis with Amphotericin B in Stable Albumin Microspheres. Antimicrob. Agents Chemother. 48: 3246-3252 [Abstract] [Full Text]  
  • Grant, K. M., Dunion, M. H., Yardley, V., Skaltsounis, A.-L., Marko, D., Eisenbrand, G., Croft, S. L., Meijer, L., Mottram, J. C. (2004). Inhibitors of Leishmania mexicana CRK3 Cyclin-Dependent Kinase: Chemical Library Screen and Antileishmanial Activity. Antimicrob. Agents Chemother. 48: 3033-3042 [Abstract] [Full Text]  
  • Mendez, S., Reckling, S. K., Piccirillo, C. A., Sacks, D., Belkaid, Y. (2004). Role for CD4+ CD25+ Regulatory T Cells in Reactivation of Persistent Leishmaniasis and Control of Concomitant Immunity. JEM 200: 201-210 [Abstract] [Full Text]  
  • Vilaplana, C., Blanco, S., Dominguez, J., Gimenez, M., Ausina, V., Munoz, C. (2004). Noninvasive Method for Diagnosis of Visceral Leishmaniasis by a Latex Agglutination Test for Detection of Antigens in Urine Samples. J. Clin. Microbiol. 42: 1853-1854 [Full Text]  
  • MIRA, J. A., CORZO, J. E., RIVERO, A., MACIAS, J., DE LEON, F. L., TORRE-CISNEROS, J., GOMEZ-MATEOS, J., JURADO, R., PINEDA, J. A. (2004). FREQUENCY OF VISCERAL LEISHMANIASIS RELAPSES IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY. Am J Trop Med Hyg 70: 298-301 [Abstract] [Full Text]  
  • Ravindran, R., Anam, K., Bairagi, B. C., Saha, B., Pramanik, N., Guha, S. K., Goswami, R. P., Banerjee, D., Ali, N. (2004). Characterization of Immunoglobulin G and Its Subclass Response to Indian Kala-Azar Infection before and after Chemotherapy. Infect. Immun. 72: 863-870 [Abstract] [Full Text]  
  • Spath, G. F., Lye, L.-F., Segawa, H., Sacks, D. L., Turco, S. J., Beverley, S. M. (2003). Persistence Without Pathology in Phosphoglycan-Deficient Leishmania major. Science 301: 1241-1243 [Abstract] [Full Text]  
  • Worthey, E. A., Martinez-Calvillo, S., Schnaufer, A., Aggarwal, G., Cawthra, J., Fazelinia, G., Fong, C., Fu, G., Hassebrock, M., Hixson, G., Ivens, A. C., Kiser, P., Marsolini, F., Rickell, E., Salavati, R., Sisk, E., Sunkin, S. M., Stuart, K. D., Myler, P. J. (2003). Leishmania major chromosome 3 contains two long convergent polycistronic gene clusters separated by a tRNA gene. Nucleic Acids Res 31: 4201-4210 [Abstract] [Full Text]  
  • Marfurt, J., Nasereddin, A., Niederwieser, I., Jaffe, C. L., Beck, H.-P., Felger, I. (2003). Identification and Differentiation of Leishmania Species in Clinical Samples by PCR Amplification of the Miniexon Sequence and Subsequent Restriction Fragment Length Polymorphism Analysis. J. Clin. Microbiol. 41: 3147-3153 [Abstract] [Full Text]  
  • Rosa, M. d. S. S., Mendonca-Filho, R. R., Bizzo, H. R., Rodrigues, I. d. A., Soares, R. M. A., Souto-Padron, T., Alviano, C. S., Lopes, A. H. C. S. (2003). Antileishmanial Activity of a Linalool-Rich Essential Oil from Croton cajucara. Antimicrob. Agents Chemother. 47: 1895-1901 [Abstract] [Full Text]  
  • Gangneux, J.-P., Menotti, J., Lorenzo, F., Sarfati, C., Blanche, H., Bui, H., Pratlong, F., Garin, Y.-J.-F., Derouin, F. (2003). Prospective Value of PCR Amplification and Sequencing for Diagnosis and Typing of Old World Leishmania Infections in an Area of Nonendemicity. J. Clin. Microbiol. 41: 1419-1422 [Abstract] [Full Text]  
  • Schulz, A., Mellenthin, K., Schonian, G., Fleischer, B., Drosten, C. (2003). Detection, Differentiation, and Quantitation of Pathogenic Leishmania Organisms by a Fluorescence Resonance Energy Transfer-Based Real-Time PCR Assay. J. Clin. Microbiol. 41: 1529-1535 [Abstract] [Full Text]  
  • Sundar, S., Rai, M. (2002). Laboratory Diagnosis of Visceral Leishmaniasis. CVI 9: 951-958 [Full Text]  
  • Altet, L., Francino, O., Solano-Gallego, L., Renier, C., Sanchez, A. (2002). Mapping and Sequencing of the Canine NRAMP1 Gene and Identification of Mutations in Leishmaniasis-Susceptible Dogs. Infect. Immun. 70: 2763-2771 [Abstract] [Full Text]  
  • Katz, K. C., Walmsley, S. L., McLeod, A. G., Keystone, J. S., Detsky, A. S. (2002). Where Are You From?. NEJM 346: 764-767 [Full Text]  
  • Belkaid, Y., Hoffmann, K. F., Mendez, S., Kamhawi, S., Udey, M. C., Wynn, T. A., Sacks, D. L. (2001). The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti-IL-10 Receptor Antibody for Sterile Cure. JEM 194: 1497-1506 [Abstract] [Full Text]  
  • Murray, H. W. (2001). Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis. Antimicrob. Agents Chemother. 45: 2185-2197 [Full Text]  
  • Escobar, P., Yardley, V., Croft, S. L. (2001). Activities of Hexadecylphosphocholine (Miltefosine), AmBisome, and Sodium Stibogluconate (Pentostam) against Leishmania donovani in Immunodeficient scid Mice. Antimicrob. Agents Chemother. 45: 1872-1875 [Abstract] [Full Text]  
  • Sereno, D., Roy, G., Lemesre, J. L., Papadopoulou, B., Ouellette, M. (2001). DNA Transformation of Leishmania infantum Axenic Amastigotes and Their Use in Drug Screening. Antimicrob. Agents Chemother. 45: 1168-1173 [Abstract] [Full Text]  
  • Lachaud, L., Chabbert, E., Dubessay, P., Reynes, J., Lamothe, J., Bastien, P. (2001). Comparison of Various Sample Preparation Methods for PCR Diagnosis of Visceral Leishmaniasis Using Peripheral Blood. J. Clin. Microbiol. 39: 613-617 [Abstract] [Full Text]  
  • Carrio, J., Riera, C., Gallego, M., Ribera, E., Portus, M. (2001). In vitro susceptibility of Leishmania infantum to meglumine antimoniate in isolates from repeated leishmaniasis episodes in HIV-coinfected patients. J Antimicrob Chemother 47: 120-121 [Full Text]  
  • Pizzuto, M., Piazza, M., Senese, D., Scalamogna, C., Calattini, S., Corsico, L., Persico, T., Adriani, B., Magni, C., Guaraldi, G., Gaiera, G., Ludovisi, A., Gramiccia, M., Galli, M., Moroni, M., Corbellino, M., Antinori, S. (2001). Role of PCR in Diagnosis and Prognosis of Visceral Leishmaniasis in Patients Coinfected with Human Immunodeficiency Virus Type 1. J. Clin. Microbiol. 39: 357-361 [Abstract] [Full Text]  
  • Probst, P., Stromberg, E., Ghalib, H. W., Mozel, M., Badaro, R., Reed, S. G., Webb, J. R. (2001). Identification and Characterization of T Cell-Stimulating Antigens from Leishmania by CD4 T Cell Expression Cloning. J. Immunol. 166: 498-505 [Abstract] [Full Text]  
  • Nicolas, L., Sidjanski, S., Colle, J.-H., Milon, G. (2000). Leishmania major Reaches Distant Cutaneous Sites Where It Persists Transiently while Persisting Durably in the Primary Dermal Site and Its Draining Lymph Node: a Study with Laboratory Mice. Infect. Immun. 68: 6561-6566 [Abstract] [Full Text]  
  • Murray, H. W. (2000). Suppression of Posttreatment Recurrence of Experimental Visceral Leishmaniasis in T-Cell-Deficient Mice by Oral Miltefosine. Antimicrob. Agents Chemother. 44: 3235-3236 [Abstract] [Full Text]  
  • Zaitseva, M., Lee, S., Lapham, C., Taffs, R., King, L., Romantseva, T., Manischewitz, J., Golding, H. (2000). Interferon gamma and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection. Blood 96: 3109-3117 [Abstract] [Full Text]  
  • Melby, P. C., Ogden, G. B., Flores, H. A., Zhao, W., Geldmacher, C., Biediger, N. M., Ahuja, S. K., Uranga, J., Melendez, M. (2000). Identification of Vaccine Candidates for Experimental Visceral Leishmaniasis by Immunization with Sequential Fractions of a cDNA Expression Library. Infect. Immun. 68: 5595-5602 [Abstract] [Full Text]  
  • Smith, A. C., Yardley, V., Rhodes, J., Croft, S. L. (2000). Activity of the Novel Immunomodulatory Compound Tucaresol against Experimental Visceral Leishmaniasis. Antimicrob. Agents Chemother. 44: 1494-1498 [Abstract] [Full Text]  
  • Murray, H. W, Pépin, J., Nutman, T. B, Hoffman, S. L, Mahmoud, A. A F (2000). Recent advances: Tropical medicine. BMJ 320: 490-494 [Full Text]  
  • Suffia, I., Ferrua, B., Stien, X., Mograbi, B., Marty, P., Rousseau, D., Fragaki, K., Kubar, J. (2000). A Novel Leishmania infantum Recombinant Antigen Which Elicits Interleukin 10 Production by Peripheral Blood Mononuclear Cells of Patients with Visceral Leishmaniasis. Infect. Immun. 68: 630-636 [Abstract] [Full Text]  
  • Cuvillier, A, Redon, F, Antoine, J., Chardin, P, DeVos, T, Merlin, G (2000). LdARL-3A, a Leishmania promastigote-specific ADP-ribosylation factor-like protein, is essential for flagellum integrity. J. Cell Sci. 113: 2065-2074 [Abstract]  
  • Santos-Gomes, G., Gomes-Pereira, S., Campino, L., Araújo, M. D. A., Abranches, P. (2000). Performance of Immunoblotting in Diagnosis of Visceral Leishmaniasis in Human Immunodeficiency Virus-Leishmania sp.-Coinfected Patients. J. Clin. Microbiol. 38: 175-178 [Abstract] [Full Text]  
  • Lachaud, L., Dereure, J., Chabbert, E., Reynes, J., Mauboussin, J.-M., Oziol, E., Dedet, J.-P., Bastien, P. (2000). Optimized PCR Using Patient Blood Samples For Diagnosis and Follow-Up of Visceral Leishmaniasis, with Special Reference to AIDS Patients. J. Clin. Microbiol. 38: 236-240 [Abstract] [Full Text]  
  • Al-Abdely, H. M., Graybill, J. R., Loebenberg, D., Melby, P. C. (1999). Efficacy of the Triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous and Visceral Leishmaniases. Antimicrob. Agents Chemother. 43: 2910-2914 [Abstract] [Full Text]  
  • Wolday, D., Akuffo, H., Demissie, A., Britton, S. (1999). Role of Leishmania donovani and Its Lipophosphoglycan in CD4+ T-cell Activation-Induced Human Immunodeficiency Virus Replication. Infect. Immun. 67: 5258-5264 [Abstract] [Full Text]  
  • Garcia-Hermoso, D., Janbon, G., Dromer, F. (1999). Epidemiological Evidence for Dormant Cryptococcus neoformans Infection. J. Clin. Microbiol. 37: 3204-3209 [Abstract] [Full Text]  
  • le Fichoux, Y., Quaranta, J.-F., Aufeuvre, J.-P., Lelievre, A., Marty, P., Suffia, I., Rousseau, D., Kubar, J. (1999). Occurrence of Leishmania infantum Parasitemia in Asymptomatic Blood Donors Living in an Area of Endemicity in Southern France. J. Clin. Microbiol. 37: 1953-1957 [Abstract] [Full Text]  
  • Gangneux, J.-P., Dullin, M., Sulahian, A., Garin, Y. J.-F., Derouin, F. (1999). Experimental Evaluation of Second-Line Oral Treatments of Visceral Leishmaniasis Caused by Leishmania infantum. Antimicrob. Agents Chemother. 43: 172-174 [Abstract] [Full Text]  
  • Al-Abdely, H. M., Graybill, J. R., Bocanegra, R., Najvar, L., Montalbo, E., Regen, S. L., Melby, P. C. (1998). Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous Leishmaniasis and Visceral Leishmaniasis. Antimicrob. Agents Chemother. 42: 2542-2548 [Abstract] [Full Text]  
  • Durand, R., Paul, M., Pratlong, F., Rivollet, D., Dubreuil-Lemaire, M.-L., Houin, R., Astier, A., Deniau, M. (1998). Leishmania infantum: Lack of Parasite Resistance to Amphotericin B in a Clinically Resistant Visceral Leishmaniasis. Antimicrob. Agents Chemother. 42: 2141-2143 [Abstract] [Full Text]  
  • Jha, T K, Olliaro, P, Thakur, C P N, Kanyok, T P, Singhania, B L, Singh, I J, Singh, N K P, Akhoury, S, Jha, S, Lockwood, D. N J (1998). Randomised controlled trial of aminosidine (paromomycin) v sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India • Commentary: Some good news for treatment of visceral leishmaniasis in Bihar. BMJ 316: 1200-1205 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»